Citation Impact
Citing Papers
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Amyloid beta: structure, biology and structure-based therapeutic development
2017
Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context
2006 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Sepsis biomarkers: a review
2010 Standout
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Phage display as a tool for the directed evolution of enzymes
2003
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Survey of the year 2004 commercial optical biosensor literature
2005
The road to fully programmable protein catalysis
2022 StandoutNatureNobel
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Regulation of immune tolerance by anti-inflammatory neuropeptides
2006
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Alzheimer's Disease
2010 Standout
Survey of the year 2003 commercial optical biosensor literature
2004
Effect of trehalose on protein structure
2008 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens
2006
β‐Amyloid Degradation and Alzheimer′s Disease
2006
Proteolytic Degradation of Amyloid -Protein
2012
Immunity to fungal infections
2011 Standout
ICER/CREM‐mediated transcriptional attenuation of IL‐2 and its role in suppression by regulatory T cells
2007 StandoutNobel
Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies
2003
Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems
2010 Standout
Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42
2005
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
State of play and clinical prospects of antibody gene transfer
2017
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Enzyme Mimics: Advances and Applications
2016
High levels of catalytic antibodies correlate with favorable outcome in sepsis
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
2008
Structure-Based Design of Functional Amyloid Materials
2014 StandoutNobel
Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold
2009
Neutralizing antibodies to HIV-1 induced by immunization
2013
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Immunotherapy for Alzheimer's disease
2004
The NMR–Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope
2015 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Antibody–Enzyme Fusion Proteins for Cancer Therapy
2011
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Nanomaterials for Diagnosis: Challenges and Applications in Smart Devices Based on Molecular Recognition
2014
Filamentous Phage Display in the New Millennium
2005
Works of Stephanie Planque being referenced
Toward Effective HIV Vaccination
2009
Exceptional Amyloid β Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds
2008
Antigen-specific Proteolysis by Hybrid Antibodies Containing Promiscuous Proteolytic Light Chains Paired with an Antigen-binding Heavy Chain
2009
Catalytic antibodies to amyloid β peptide in defense against Alzheimer disease
2008
Catalytic Immunoglobulin Gene Delivery in a Mouse Model of Alzheimer’s Disease: Prophylactic and Therapeutic Applications
2014
Catalytic antibodies to HIV: Physiological role and potential clinical utility
2008
Immunological Origin and Functional Properties of Catalytic Autoantibodies to Amyloid β Peptide
2010
Nature and Nurture of Catalytic Antibodies
2012
Theory of proteolytic antibody occurrence
2005
Phosphonate Ester Probes for Proteolytic Antibodies
2001
Metal-dependent amyloid β-degrading catalytic antibody construct
2014
Ontogeny of Proteolytic Immunity
2004
Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity
2005
Antibodies as defensive enzymes
2005
Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus, and autoimmune mice
2003
VIPase autoantibodies in Fas ‐defective mice and patients with autoimmune disease
2003
Lupus-Derived Antiprothrombin Autoantibodies from a V Gene Phage Display Library Are Specific for the Kringle 2 Domain of Prothrombin
2004
Degradation of β-Amyloid by Proteolytic Antibody Light Chains
2003